sFlt-1 inhibits these actions by binding to VEGF and placental growth factor (PlGF) in the circulating blood, resulting in vasoconstriction-induced hypertension, organ damage, and thrombocytopenia due to thrombus formation. Here, VEGFA is linked to Thrombocytopenia.